While current treatment options, including antibody-based drugs, offer some relief, they can be costly and not universally accessible. Alternative approaches, such as nucleic acid-based treatments ...

Nucleic acid medicine allows for rational drug design and synthesis. “We can do it in the lab, we can do it fast, and we can scale it up,” he explains. “This is a huge transformation in how ...

DNA hydrogels are biocompatible drug delivery systems for targeted therapeutic interventions. Conventional DNA hydrogels, formed with many DNA nanostructure units, lead to increased preparation costs ...

Hydrogels are polymeric materials with three-dimensional network structures containing large amounts of water. They serve as sustained-release drug delivery systems as they can encapsulate various ...

Gertrude Elion (1918–1999) and colleague George Hitchings (1905–1998) went off the beaten path of trial-and-error drug development to revolutionize drug making ...

First Solid Tumor Patient Treated with Second, Higher Dose in Phase 1/1b BP1001-A Clinical Trial Experienced Tumor Reduction and Continued Stable ...

Bio-Path (BPTH) announced the receipt of newly issued patents in the United States and New Zealand, and updated investors on the extent of its ...

In response to this gap, leaders in the nucleic acid synthesis industry took a step towards self ... She has previously written for BioTechniques News, The Scientist, and Drug Discovery News.

This nucleic acid extraction expansion will help laboratories ... of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb3(b)(1), unless the declaration is terminated, or authorization ...

Panel asks govt to ensure consistent supply of drugs, scaling up testing facilities against TB: Gireesh Babu, New Delhi Monday, February 10, 2025, 08:00 Hrs [IST] A Parliamentary ...